Please login to the form below

Not currently logged in
Email:
Password:

John LaMattina joins Frequency Therapeutics in advisory role

The ex-Pfizer R&D head will sit on its Scientific Advisory Board

John LaMattinaFrequency Therapeutics has appointed John LaMattina as its senior advisor to the CEO in a role that will see him focus on assisting its development of a treatment for hearing loss, serving on the firm’s Scientific Advisory Board.

LaMattina was previously president of Pfizer’s Global Research and Development department and senior vice president and spent 30 years at the pharma company.

He said: “It is my pleasure to join Frequency Therapeutics as it begins clinical development of a treatment for hearing loss.

“The team has made remarkably rapid progress, and Frequency’s Progenitor Cell Activation platform presents an exceptional opportunity to develop a wide range of new-disease modifying therapies for hearing and other areas throughout the body.”

Alongside his new role LaMattina will continue to serve as an independent non-executive director at PureTech Health.

David Lucchino, president, co-founder and CEO of Frequences Therapeutics, said: “As a highly-regarded industry veteran, John brings us a wealth of knowledge and expertise.

"John has already begun to help us accelerate the development of our pipeline of product candidates for hearing restoration.”

4th April 2017

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
infill healthcare communication

infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics